Imaging in Neuromuscular Disease 2017

19 – 21 November 2017

The conference program will feature internationally-recognized keynote speakers highlighting developments and advances in all aspects of muscle imaging. At least 200 participants from the neuromuscular field are expected to attend. Key note speakers include Andrew Blamire, Carsten Bonnemann, Pierre Carlier, Bruce Damon, Kieren Hollingsworth, Hermien Kan, Richard Lerski, Martin Meyerspeer, George Radda, Fritz Schick, Volker Straub, Gustav Strijkers, Giorgio Tasca, Krista Vandenborne and Felix Wehrli.

The Imaging in Neuromuscular Disease Conference will be organized by the MYO-MRI project, a consortium supported by COST, the European Cooperation in Science and Technology. MYO-MRI focusses on applications of MR imaging and spectroscopy techniques in neuromuscular disease and has enabled collaboration on MRI as an outcome measure and on pattern recognition for diagnostics and therapy development. The project has addressed the challenges of applying MR techniques in both clinical trials and everyday clinical settings.

The Imaging in Neuromuscular Diseases Conference will highlight key findings from MYO-MRI and will discuss next steps of interest to academia and industries.

The programme will feature plenary talks on the following topics; Diagnostic Muscle Imaging, New Imaging Techniques and Quantitative Muscle Imaging – with plenary sessions and invited abstracts on each.

Langenbeck-Virchow-Haus, Luisenstr 58/59, 10117 Berlin, Germany


Luisenstr 58/59
10117 Berlin

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission

“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit